Indications and uses
temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches backache menstrual cramps headache toothache the common cold temporarily reduces fever
temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches backache menstrual cramps headache toothache the common cold temporarily reduces fever
do not take more than directed the smallest effective dose should be used drink a full glass of water with each dose Adults and children 12 years and older take 1 tablet/caplet every 8 to 12 hours while symptoms last for the first dose you may take 2 tablets/caplets within the first hour do not exceed 2 tablets/caplets in any 8 to 12 hour period do not exceed 3 tablets/caplets in a 24-hour period Children under 12...
each tablet/caplet contains: sodium 20 mg store at 20-25°C (68-77°F). Avoid high humidity and excessive heat above 40°C (104°F).
PAIN RELIEVER / FEVER REDUCER (NSAID)
Drug Facts
Pain reliever/fever reducer
Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
Do not use
Ask a doctor before use if
Ask a doctor or pharmacist before use if you are
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| Adults and children 12 years and older |
|
| Children under 12 years |
|
FD &C Blue # 2, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, povidone, talc, titanium dioxide
call toll-free weekdays 9 AM to 8 PM EST at 1-888-375-3784
Distributed by:
Dr. Reddy’s Laboratories, Inc.
Princeton, NJ 08540
Made in India
Rev: 03/2022
Headache Pain - Caplet Container
Headache Pain - Caplet Carton
Headache Pain - Tablet Container
Headache Pain - Tablet Container Carton
Back and Muscle Pain - Caplet Container
Back & Muscle Pain - Caplet Container Carton
Back and Muscle Pain - Tablet Container
Back and Muscle Pain - Tablet Container Carton
| Class | Version | Type | Effective |
|---|---|---|---|
| NAPROXEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-071-01 | Naproxen Sodium Headache Pain | 1 in 1 CARTON | TABLET, COATED | 1 | 6 | |
| 43598-071-01 | Naproxen Sodium Headache Pain | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 43598-072-01 | Naproxen Sodium Headache Pain | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 43598-072-01 | Naproxen Sodium Headache Pain | 1 in 1 CARTON | TABLET, COATED | 1 | 6 | |
| 43598-073-01 | Naproxen Sodium Back and Muscle Pain | 1 in 1 CARTON | TABLET, COATED | 1 | 6 | |
| 43598-073-01 | Naproxen Sodium Back and Muscle Pain | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 43598-074-01 | Naproxen Sodium Back and Muscle Pain | 100 in 1 BOTTLE | TABLET, COATED | 100 | 6 | |
| 43598-074-01 | Naproxen Sodium Back and Muscle Pain | 1 in 1 CARTON | TABLET, COATED | 1 | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43598-071 | 43598-071-01 |
| 43598-072 | 43598-072-01 |
| 43598-073 | 43598-073-01 |
| 43598-074 | 43598-074-01 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075168-001 | NAPROXEN SODIUM | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A075168-001 | NAPROXEN SODIUM | EQ 200MG BASE | TABLET / ORAL | 1998-07-28 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A075168-001 | NAPROXEN SODIUM | EQ 200MG BASE | TABLET / ORAL | 1998-07-28 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A075168-001 | NAPROXEN SODIUM | 220MG | TABLET / ORAL | 1998-07-28 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen Sodium Headache Pain | NAPROXEN SODIUM | Dr.Reddy's Laboratories Inc | 12e45b43-eca2-73f4-1d68-07d4238f8c70 | 2025-06-03 | Warnings | 43598-072-01 43598-073-01 43598-074-01 43598-071-01 43598-073 43598-074 43598-071 43598-072 43598007301 43598007401 43598007101 43598007201 c94f5885-67ab-4e95-df53-a58f119c504b 12e45b43-eca2-73f4-1d68-07d4238f8c70 |
Adverse event summaries are temporarily unavailable. Other product information remains available.